GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024 – Two accepted abstracts highlight innovative methods for gene expression regulation – – GeneFab’s synthetic biology capabilities and Advanced Therapies offerings enable development of affordable...

GeneFab Launches to Offer Innovative Manufacturing and Synthetic Biology Design Services for a Broad Range of Genetic Medicines – GeneFab’s cGMP facility in the San Francisco Bay Area has available capacity to support new customers with complex cell and gene therapy manufacturing, including allogeneic and autologous cell...